Asia Vital Components Co Ltd
OTC:AVMPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Asia Vital Components Co Ltd
OTC:AVMPF
|
TW |
|
L
|
Link Administration Holdings Ltd
ASX:LNK
|
AU |
|
Celltrion Inc
KRX:068270
|
KR |
|
Alexander & Baldwin Inc (Hawaii)
NYSE:ALEX
|
US |
|
Usinas Siderurgicas de Minas Gerais SA USIMINAS
BOVESPA:USIM5
|
BR |
|
H
|
Hyungji Innovation and Creative Co Ltd
KOSDAQ:011080
|
KR |
|
Reliance Global Group Inc
NASDAQ:RELI
|
US |
|
Profound Medical Corp
TSX:PRN
|
CA |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
Wall St Price Targets
AVMPF Price Targets Summary
Asia Vital Components Co Ltd
According to Wall Street analysts, the average 1-year price target for AVMPF is 31.316 USD with a low forecast of 20.433 USD and a high forecast of 36.062 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVMPF's stock price target?
Price Target
31.316
USD
According to Wall Street analysts, the average 1-year price target for AVMPF is 31.316 USD with a low forecast of 20.433 USD and a high forecast of 36.062 USD.
What is the Revenue forecast for Asia Vital Components Co Ltd?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 37%.
What is the Operating Income forecast for Asia Vital Components Co Ltd?
Projected CAGR
38%
Over the last 14 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is 38%.
What is the Net Income forecast for Asia Vital Components Co Ltd?
Projected CAGR
49%
Over the last 14 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 49%.
